Drug Profile
Celecoxib/Tramadol - YooYoung Pharmaceuticals
Alternative Names: YYC301Latest Information Update: 09 Feb 2022
Price :
$50
*
At a glance
- Originator Yooyoung Pharmaceutical
- Class Analgesics; Anti-inflammatories; Cyclohexanols; Dimethylamines; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Opioid analgesics; Phenyl ethers; Pyrazoles; Small molecules; Sulfonamides
- Mechanism of Action Adrenergic uptake inhibitors; Cyclo-oxygenase 2 inhibitors; Opioid mu receptor agonists; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Osteoarthritis
- No development reported Pain
Most Recent Events
- 11 Nov 2021 Phase-III clinical trials in Osteoarthritis (Monotherapy) in South Korea (PO) (NCT05362851)
- 28 Jan 2020 No recent reports of development identified for preclinical development in Pain in South Korea (PO, Capsule)
- 06 Mar 2019 Chemical structure information added